OncoSil Medical Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.02 |
Market Cap |
AUD34.69 M |
Shares Outstanding |
630.71 M |
Public Float |
486.16 M |
Address |
50 Berry Street North Sydney New South Wales (NSW) 2060 Australia |
Employees | - |
Website | http://www.oncosil.com.au |
Updated | 07/08/2019 |
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It is engaged in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia. |